drugset / Trial / NCT06599151

PETMRI for Chronic Pain from Spinal or Peripheral Nerve Origin

NCT06599151 ↗

Phase 1 Not yet recruiting 200 enrolled Stanford University
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

The purpose of this study is to compare the uptake of \[18F\]FTC-146 in healthy volunteers to that of individuals suffering from chronic pain with Spinal or Peripheral Nerve Origin. Primary Objectives: A) To quantify the bio-distribution of \[18F\] FTC-146 uptake in subjects with Spinal or Peripheral Nerve Origin pain and compare it with healthy controls. B) To determine whether painful schwannomas can be differentiated from non-painful schwannomas based on imaging. Secondary Objectives: A) To assess the reproducibility of \[18F\]FTC-146 PET imaging within the same healthy volunteer subjects using Test-Retest analysis. B) To investigate whether post-treatment \[18F\]FTC-146 uptake differs from pre-treatment uptake and correlate the imaging with subject reported pain level after treatment

Timeline

Start
2024-10-01
Primary completion
2030-10-01
Completion
2030-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-FTC-146 Diagnostic / imaging agent 185 mbq Other
Subject 18F-FTC-146 Diagnostic / imaging agent 370 mbq Other